Standard BioTools Inc

FLB

Company Profile

  • Business description

    Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

  • Contact

    50 Milk Street
    10th Floor
    BostonMA02109
    USA

    T: +1 650 266-6000

    E: [email protected]

    https://www.standardbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    389

Stocks News & Analysis

stocks

ASX healthcare share undervalued post earnings

Short term headwinds mask long term value opportunity.
stocks

ASX energy share sees 363% increase in dividend

Geopolitical tensions drive strong profit and dividends for oil refiner.
stocks

Wide moat share remains cheap despite rising costs

Higher costs weigh on profits but stronger sales trends support long term outlook.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,338.8054.50-0.58%
CAC 408,492.0352.830.63%
DAX 4026,385.29119.150.45%
Dow JONES (US)53,513.8463.56-0.12%
FTSE 10010,914.1628.000.26%
HKSE25,652.97141.870.56%
NASDAQ26,101.6149.69-0.19%
Nikkei 22566,262.16405.730.62%
NZX 50 Index14,013.2120.490.15%
S&P 5007,678.030.750.01%
S&P/ASX 2009,127.8055.90-0.61%
SSE Composite Index3,912.5223.080.59%

Market Movers